27 February 2025
We’re bringing our successful Hepatitis C (HCV) Intervention Symposium to Australia for the first time, with events planned in Sydney, NSW, and Ipswich, Queensland later this year.
The move builds on years of experience delivering education and training to healthcare providers globally. Since 2017, our Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program has trained over 1,500 healthcare practitioners across 16 countries.
In 2022, we launched the Hepatitis C Intervention Capacity Strengthening Toolkit, which has been accessed more than 44,600 times by providers worldwide. In 2023, we introduced the HCV Intervention Symposium Project, which has trained over 630 practitioners in Canada, the UK, and the US.
The NSW symposia will closely follow our global model, while the Queensland event will be tailored specifically for Mental Health, Alcohol and Other Drug Services and aims to improve and embed HCV models of care.
What to expect:
- Our symposia are co-designed with core partners and tailored to the local environment
- Building on our Hepatitis C Intervention Toolkit and HCV Intervention Symposia model, each symposium will be interactive, featuring expert presentations, case studies, group discussions, and action planning
- The symposia aim to improve HCV care pathways and support each state’s progress toward HCV elimination
- Topics covered will include HCV epidemiology, best-practice models, and practical tools for enhancing HCV care within mental health and AOD services
- The events will be followed by a community of practice (CoP) to provide ongoing support, shared learning, and implementation guidance
“These symposia build on our experience delivering education and training to healthcare providers globally,” says Emma Day, Executive Director of INHSU. “By tailoring our successful symposium model for the specific needs of each state, we aim to strengthen care pathways and empower service providers with the knowledge and tools they need to enhance HCV care delivery. This is a crucial step toward improving health outcomes for people at risk of HCV.”
The exact dates and speakers are to be confirmed. If you’re interested in attending email [email protected].
